Impact of obstructive sleep apnea treatment in patients with atrial fibrillation having ablation: a randomised controlled trial.
Not Applicable
Recruiting
- Conditions
- Sleep ApnoeaAtrial FibrillationCardiovascular - Other cardiovascular diseasesRespiratory - Sleep apnoea
- Registration Number
- ACTRN12616000088448
- Lead Sponsor
- Royal Melbourne Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
Patients having ablation for AF
Patients with at least moderate obstructive sleep apnea defined AHI of 15 or greater.
Exclusion Criteria
Significant pulmonary disease
Life expectancy < 24 months
Severely elevated Epworth Sleepiness Scores that may pose driving risk
Involvement in another trial that will compromise this trial
Reversible cause of AF
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method